Get the Stockscreener App
194.31
1.44%
2.76
After Hours:
194.31
Penumbra Inc stock is traded at $194.31, with a volume of 292.23K.
It is up +1.44% in the last 24 hours and down -3.96% over the past month.
Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States.
See More
Previous Close:
$191.55
Open:
$191.12
24h Volume:
292.23K
Relative Volume:
0.64
Market Cap:
$7.55B
Revenue:
$1.13B
Net Income/Loss:
$14.23M
P/E Ratio:
188.65
EPS:
1.03
Net Cash Flow:
$110.67M
1W Performance:
-0.30%
1M Performance:
-3.96%
6M Performance:
-12.94%
1Y Performance:
-19.68%
1-Day Range:
$191.12
$194.44
1-Week Range:
$185.13
$195.95
52-Week Range:
$148.00
$277.34
Penumbra Inc Stock (PEN) Company Profile
Name
Penumbra Inc
Sector
Industry
Phone
(510) 995-2486
Address
ONE PENUMBRA PLACE, ALAMEDA, CA
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-06-23 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Mar-29-23 | Downgrade | Needham | Buy → Hold |
| Jan-30-23 | Initiated | Piper Sandler | Overweight |
| Nov-04-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-05-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-09-22 | Upgrade | Needham | Hold → Buy |
| Jul-18-22 | Initiated | RBC Capital Mkts | Outperform |
| Apr-19-22 | Initiated | Deutsche Bank | Buy |
| Mar-08-22 | Initiated | Needham | Hold |
| Sep-16-21 | Initiated | Truist | Buy |
| Jun-04-21 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-20 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-07-20 | Resumed | Canaccord Genuity | Buy |
| Sep-29-20 | Initiated | BTIG Research | Buy |
| Sep-08-20 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Jun-13-19 | Reiterated | BofA/Merrill | Buy |
| May-30-19 | Upgrade | JP Morgan | Neutral → Overweight |
| May-21-19 | Initiated | William Blair | Outperform |
| Oct-29-18 | Resumed | BofA/Merrill | Buy |
| Oct-08-18 | Initiated | RBC Capital Mkts | Outperform |
| Feb-21-18 | Initiated | William Blair | Outperform |
| Jan-02-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Reiterated | Canaccord Genuity | Buy |
| Oct-13-15 | Initiated | Wells Fargo | Outperform |
View All
Penumbra Inc Stock (PEN) Latest News
Algert Global LLC Raises Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Hsbc Holdings PLC Increases Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
XTX Topco Ltd Has $283,000 Stake in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Envestnet Asset Management Inc. Raises Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Canada Pension Plan Investment Board Raises Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Bavarian Nordic secures additional $63m order in US for Jynneos production - World Pharmaceutical Frontiers
PEN (Penumbra) GF Score : 87/100 (As of Sep. 25, 2024) - GuruFocus.com
Bavarian Nordic gets $63 million US government order or small pox, mpox vaccine - Bahrain News Agency
Vanguard Personalized Indexing Management LLC Grows Stock Holdings in Penumbra, Inc. (NYSE:PEN) - Defense World
Bavarian Nordic gains US contract for additional mpox vaccine - Pharmaceutical Technology
Penumbra CEO Adam Elsesser sells over $2.9 million in company stock By Investing.com - Investing.com South Africa
Penumbra CEO Adam Elsesser sells over $2.9 million in company stock - Investing.com
Penumbra CEO Adam Elsesser sells over $2.9 million in company stock - Investing.com UK
Bavarian Nordic said to have won $63M mpox vaccine contract from U.S. - Seeking Alpha
Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine By Reuters - Investing.com
Bavarian Nordic Secures $63 Million U.S. Government Contract for Vaccine Production - Devdiscourse
Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine - Yahoo! Voices
3,986 Shares in Penumbra, Inc. (NYSE:PEN) Bought by Mount Yale Investment Advisors LLC - MarketBeat
Intech Investment Management LLC Makes New $3.59 Million Investment in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra Inc (PEN) Performance and Fundamentals Dashboard tells a completely different story - SETE News
Penumbra, Inc. (NYSE:PEN) Shares Sold by Mutual of America Capital Management LLC - Defense World
64,782 Shares in Penumbra, Inc. (NYSE:PEN) Acquired by Skandinaviska Enskilda Banken AB publ - MarketBeat
When the Price of (PEN) Talks, People Listen - Stock Traders Daily
Twin studies show Bavarian Nordic’s Mpox vax efficacy wanes in 1 year - Yes Punjab
Twin studies show Bavarian Nordic’s Mpox vax efficacy wanes in 1 year - Newsroom Odisha
Why Is Penumbra (PEN) Up 20% Since Last Earnings Report? - MSN
Penumbra, Inc. (NYSE:PEN) Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
PEN Stock to Gain From CE Mark Approval for its CAVT Technologies - MSN
Penumbra (NYSE:PEN) Stock Price Up 3.9% - MarketBeat
Primecap Management Co. CA Has $7.19 Million Stock Holdings in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Why Penumbra Stock Zoomed Nearly 5% Higher Today - sharewise
Analysts Set Penumbra, Inc. (NYSE:PEN) Price Target at $208.00 - MarketBeat
Why Penumbra Stock Zoomed Nearly 5% Higher Today - MSN
Why Penumbra Stock Zoomed Nearly 5% Higher Today - The Motley Fool
Penumbra Inc (PEN) Shares Up 3.47% on Sep 18 - GuruFocus.com
Stifel sets $238 target on Penumbra, cites market growth By Investing.com - Investing.com Canada
Stifel sets $238 target on Penumbra, cites market growth - Investing.com
Stifel Nicolaus Begins Coverage on Penumbra (NYSE:PEN) - MarketBeat
Analyst Ratings For Penumbra - Benzinga
Citizens Financial Group Inc. RI Takes Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
PEN Stock to Gain From CE Mark Approval for its CAVT Technologies - Yahoo Finance
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy TechnologiesLightning Flash™ 2.0 and Lightning Bolt™ 7in Europe - The Malaysian Reserve
Penumbra wins CE mark for computer-assisted thrombectomy tech - Mass Device
Penumbra secures CE mark for CAVT technologies in Europe - Medical Device Network
Penumbra secures CE mark for CAVT technologies in Europe - Yahoo Finance
Penumbra, Inc. (NYSE:PEN) Position Raised by Headlands Technologies LLC - Defense World
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy TechnologiesLightning Flashtm 2.0 and Lightning Bolttm 7in Europe - Lelezard
Penumbra receives CE Mark for Lightning Flash 2.0 and Lightning Bolt 7 - Med-Tech Innovation
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy TechnologiesLightning Flash™ 2.0 and Lightning Bolt™ 7in Europe - StockTitan
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy TechnologiesLightning Flash™ 2.0 and Lightning Bolt™ 7in Europe - Marketscreener.com
William Blair Investment Management LLC Has $148.47 Million Stock Position in Penumbra, Inc. (NYSE:PEN) - MarketBeat
Penumbra Inc Stock (PEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):